PACTG P1025: PERINATAL CORE PROTOCOL
PACTG P1025: PERINATAL CORE PROTOCOL
批准号:
7374348
负责人:
Elizabeth Jane McFarland
金额:
$9.67万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-24 至 2007-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. PACTG P1025 is a prospective cohort study with the primary goal of enrolling pregnant, HIV-infected women receiving prenatal care at PACTG sites and their infants into a study in which clinical and laboratory (virologic, immunologic, and biochemical) data and specimens for repository storage are obtained according to a standardized protocol. It is anticipated that complementary, well-designed substudies will be developed as adjuncts to the standardized core protocol. The primary hypotheses that this study will investigate are: * Antiretroviral therapy resulting in viral loads under 1000cp/ml will be effective in reducing the risk of HIV transmission to below 1%. * Women with greater adherence to treatment will have lower viral loads. * Adherence to treatment will be greater during pregnancy than during the months following delivery. PACTG P1025 is designed to enroll a large representative sample of pregnant HIV-infected women who receive care at PACTG and collaborating sites. Women will be followed until 12 months postpartum. Infants will be followed for 6-12 months in P1025 and subsequently roll-over into PACTG 219C, a long-term observation study for HIV-exposed infants and children. Medical records will be abstracted to obtain data concerning medical history, physical examination, and laboratory studies conducted as part of clinical care. Specifically, supplemental data concerning ART use, adherence to medications, and review of symptoms relevant to side effects and toxicities will be collected through administration of questionnaires. At study visits, phlebotomy will be conducted in order to obtain specimens for a repository and to obtain specimens for required laboratory tests. At labor and delivery, attempts to collect information on placental pathology and to collect amniotic fluid for storage will be made.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University of Colorado Denver Adolescent Trials Network Unit
-
批准号:8063765
-
项目类别:
-
资助金额:$43.52万
-
财政年份:2011
-
负责人:Elizabeth Jane McFarland
-
依托单位:
University of Colorado Denver Adolescent Trials Network Unit
-
批准号:8254322
-
项目类别:
-
资助金额:$43.62万
-
财政年份:2011
-
负责人:Elizabeth Jane McFarland
-
依托单位:
University of Colorado Denver Adolescent Trials Network Unit
-
批准号:8617854
-
项目类别:
-
资助金额:$44.98万
-
财政年份:2011
-
负责人:Elizabeth Jane McFarland
-
依托单位:
University of Colorado Denver Adolescent Trials Network Unit
-
批准号:8463420
-
项目类别:
-
资助金额:$42.64万
-
财政年份:2011
-
负责人:Elizabeth Jane McFarland
-
依托单位:
PACTG 1020A: BMS232632 IN COMB REGIMENS IN ART-NAIVE & EXPERIENCED HIV CHILDREN
-
批准号:7605063
-
项目类别:
-
资助金额:$2.04万
-
财政年份:2007
-
负责人:Elizabeth Jane McFarland
-
依托单位:
ANTIRETROVIRAL THERAPY PHARMACOKINETICS DURING PUBERTY
-
批准号:7605115
-
项目类别:
-
资助金额:$7.61万
-
财政年份:2007
-
负责人:Elizabeth Jane McFarland
-
依托单位:
PACTG P1059
-
批准号:7605135
-
项目类别:
-
资助金额:$1.77万
-
财政年份:2007
-
负责人:Elizabeth Jane McFarland
-
依托单位:
PACTG P1055: PSYCHIATRIC CO-MORBIDITY IN PERINATALLY HIV CHILDREN AND ADOLESCENT
-
批准号:7605122
-
项目类别:
-
资助金额:$4.48万
-
财政年份:2007
-
负责人:Elizabeth Jane McFarland
-
依托单位:
PACTG P1026S: PHARMACOKINETIC PROPERTIES OF ANTIRETROVIRAL DRUG DURING PREGNANCY
-
批准号:7605082
-
项目类别:
-
资助金额:$4.49万
-
财政年份:2007
-
负责人:Elizabeth Jane McFarland
-
依托单位:
PACTG P1025: PERINATAL CORE PROTOCOL
-
批准号:7605074
-
项目类别:
-
资助金额:$19.18万
-
财政年份:2007
-
负责人:Elizabeth Jane McFarland
-
依托单位:
ACTG #219C: PEDIATRIC LATE OUTCOMES PROTOCOL
-
批准号:7605048
-
项目类别:
-
资助金额:$18.47万
-
财政年份:2007
-
负责人:Elizabeth Jane McFarland
-
依托单位:
PACTG P1030: LOPINAVIR/RITONAVIR IN HIV-1 INFECTED INFANTS < 6 MONTHS OF AGE
-
批准号:7605089
-
项目类别:
-
资助金额:$0.95万
-
财政年份:2007
-
负责人:Elizabeth Jane McFarland
-
依托单位:
PACTG P1021: EMTRICITABINE IN COMBINATION WITH EFAVIRENZ & DIDANOSINE
-
批准号:7605068
-
项目类别:
-
资助金额:$1.09万
-
财政年份:2007
-
负责人:Elizabeth Jane McFarland
-
依托单位:
ATN 024: TRIAL OF THREE HEPATITIS B VACCINATION SCHEMAS IN HIV-POSITIVE YOUTH
-
批准号:7605108
-
项目类别:
-
资助金额:$1.77万
-
财政年份:2007
-
负责人:Elizabeth Jane McFarland
-
依托单位:
PACTG P1047: PHASE II SAFETY AND IMMUNOGENICITY STUDY OF QUADRIVALENT
-
批准号:7605148
-
项目类别:
-
资助金额:$4.08万
-
财政年份:2007
-
负责人:Elizabeth Jane McFarland
-
依托单位:
PACTG 1034: PROTEASE-CONTAINING AND PROTEASE-SPARING HAART REGIMENS
-
批准号:7605095
-
项目类别:
-
资助金额:$0.68万
-
财政年份:2007
-
负责人:Elizabeth Jane McFarland
-
依托单位:
ANTIRETROVIRAL THERAPY PHARMACOKINETICS DURING PUBERTY
-
批准号:7374404
-
项目类别:
-
资助金额:$0.43万
-
财政年份:2006
-
负责人:Elizabeth Jane McFarland
-
依托单位:
PACTG P1026S: PHARMACOKINETIC PROPERTIES OF ANTIRETROVIRAL DRUG DURING PREGNANCY
-
批准号:7374356
-
项目类别:
-
资助金额:$1.71万
-
财政年份:2006
-
负责人:Elizabeth Jane McFarland
-
依托单位:
PACTG P1015: INTENSIFICATION OF HIV-SPECIFIC CD4 & CD8 ACTIVITY BY CYCLING HAART
-
批准号:7374339
-
项目类别:
-
资助金额:$0.71万
-
财政年份:2006
-
负责人:Elizabeth Jane McFarland
-
依托单位:
PACTG P1021: EMTRICITABINE IN COMBINATION WITH EFAVIRENZ & DIDANOSINE
-
批准号:7374341
-
项目类别:
-
资助金额:$3.13万
-
财政年份:2006
-
负责人:Elizabeth Jane McFarland
-
依托单位:
海外基金